AI assistant
Fulgent Genetics, Inc. — Director's Dealing 2019
Aug 5, 2019
32553_dirs_2019-08-05_ef885008-b95d-4e51-b564-3321b9312007.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Fulgent Genetics, Inc. (FLGT)
CIK: 0001674930
Period of Report: 2019-08-01
Reporting Person: KIM PAUL (CFO and Treasurer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-08-01 | Common Stock | A | 15000 | $0.00 | Acquired | 413611 | Direct |
Footnotes
F1: Reflects an award of restricted stock units relating to 15,000 shares of the Issuer's common stock. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The shares subject to the restricted stock units vest over a period of four years, with 1/4th of such shares vesting 12 months after August 1, 2019, and 1/16th of the remaining shares vesting at the end of every three-month period over the remaining 36 months, subject to Mr. Kim's continued service for Issuer on each vesting date.